The 4th Russian-British Business Forum (RBBF), held in London on 26–27 November, will serve as a platform for promoting the Russian-British dialogue on developing bilateral trade relations. The exchange of information on projects and on companies interested in doing business in Russia and the UK started several months ago, after… Continue reading →
According to the British customs statistics, from January to June 2018 Russia’s non-resource non-energy export to the UK has shown substantial improvements – it rose by 21,7% as a consequence of the growing trade turnover between Russia and the UK.
UK and Russian stocks currently offer the best value global market opportunities, according to wealth manager Coutts. The UK benefited from strong tailwinds in the second quarter of 2018, despite being unloved by investors. While Russian stocks have been one of the best performing in 2018 year-to-date, they are still… Continue reading →
On May 24, 2018, GSK and Servier signed an agreement to launch the manufacturing of innovative HIV drug Tivicay® (INN: dolutegravir) in the production facility of Servier Rus pharmaceutical plant in Moscow. Under the terms of agreement, the full-cycle manufacturing of finished dosage form will be launched no later than… Continue reading →